SRPT CLASS ACTION: Sarepta Therapeutics Investors that Lost Money may have been Affected by Fraud — Contact BFA Law by August 25 Legal Deadline (NASDAQ:SRPT)
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Sarepta, you are encouraged to obtain […]